RSSL announces launch of new innovation hub to support biotech companies

By Liza Laws

- Last updated on GMT

© Getty Images
© Getty Images

Related tags Collaboration Innovation cell and gene therapies Laboratory regulatory compliance

RSSL, a leading pharmaceutical contract research organisation, has unveiled plans for its newest venture, the Innovation Hub.

This dedicated platform aims to bolster small- and medium-sized biotech organisations by providing them with essential resources and support to expedite the development of cutting-edge products.

Jacinta George, managing director of RSSL, expressed the company's vision, stating: "Our goal is to drive vital research and support innovation across the entire life science sector."

The Innovation Hub will serve as an invaluable ecosystem for early-stage biotech firms, offering a plethora of tailored services to facilitate their journey from concept to commercialisation. Clients partnering with RSSL will gain access to cutting-edge laboratory space equipped with state-of-the-art instrumentation, coupled with the expertise of RSSL's seasoned professionals and an extensive network of industry contacts.

"We're incredibly proud to be providing our support," George continued. "Through this collaboration, we’re excited to help them develop the next wave of groundbreaking products — from life-changing cell and gene therapies to next-generation vaccines and medical devices."

The platform introduces four distinct models to cater to the diverse needs of clients, the first is innovate - to provide access to laboratory space and equipment, with the option to utilize RSSL’s services as needed, the second is forge - to offers laboratory space, equipment, and services, along with consultancy in crucial areas such as training and regulatory compliance. The third is called launchpad and is tailored for clients seeking support with commercial development and finally 360  that offers comprehensive support across the entire development pipeline, from initial concept to commercial manufacturing.

This announcement aligns with RSSL's ambitious expansion strategy, which aims to enhance operational capacity and broaden service offerings. Recent endeavors include the inauguration of a state-of-the-art analytical testing facility, adding 26,000 sq. ft. of working laboratory space. Additionally, the company plans to double its scientific team over the next three years.

RSSL says it is proud to stand at the forefront of contract research organisations, utilizing science and innovation to foster a safer, healthier, and more sustainable world. Clients rely on RSSL to deliver innovative solutions through rigorous analytical testing, cutting-edge research and development, bespoke consultancy, and training services.

Related news

Follow us